SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Severance H Leigh – ‘4’ for 4/18/05 re: Lifevantage Corp.

On:  Friday, 7/22/05, at 4:14pm ET   ·   For:  4/18/05   ·   As:  Director   ·   Accession #:  1108890-5-506   ·   File #:  0-30489

Previous ‘4’:  ‘4’ on 7/22/05 for 5/16/05   ·   Next:  ‘4’ on 8/31/05 for 8/29/05   ·   Latest:  ‘4’ on 12/17/12 for 12/13/12

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/22/05  Severance H Leigh                 4          Director    1:25K  Lifeline Therapeutics, Inc.       Wadolny Jeffrey D/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     24K 
                Securities by an Insider --                                      
                form4severance041805_ex.xml/2.2                                  




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
SEVERANCE H LEIGH

(Last)(First)(Middle)
14282 E. CALEY WAY

(Street)
AURORACO80016

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
LIFELINE THERAPEUTICS, INC. [ LFLT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
4/18/05
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock 4/18/05 C 200,858A$0.5200,858D
Common Stock 4/18/05 C 126,884A$2327,742D
Common Stock 4/18/05 C 5,077A$25,077IBy Wife
Common Stock 4/18/05 C 81,391A$281,391IBy Trust (1)
Common Stock 4/18/05 C 45,864A$245,864IBy Trust (2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Convertible Note$0.5 4/18/05 C 200,858 2/8/05 4/18/05Common Stock200,858$0.50 (3)D (3)
Bridge Note$2 4/18/05 C 5,077 2/3/05 4/18/05Common Stock5,077$20 (3)D (3)
Bridge Note$2 4/18/05 C 126,884 2/4/05 4/18/05Common Stock126,884$20 (3)D (3)
Bridge Note$2 4/18/05 C 81,391 2/4/05 4/18/05Common Stock81,391$20 (3)D (3)
Bridge Note$2 4/18/05 C 45,864 2/4/05 4/18/05Common Stock45,864$20 (3)D (3)
Bridge Note Warrants$2 4/18/05 C 5,077 4/18/05 4/18/08Common Stock5,077$25,077IBy Wife
Bridge Note Warrants$2 4/18/05 C 81,391 4/18/05 4/18/08Common Stock81,391$281,391IBy Trust (1)
Bridge Note Warrants$2 4/18/05 C 45,864 4/18/05 4/18/08Common Stock45,864$245,864IBy Trust (2)
Bridge Note Warrants$2 4/18/05 C 126,884 4/18/05 4/18/08Common Stock126,884$2126,884D
Unit Warrants$2.5 4/18/05 C 5,077 4/18/05 4/18/08Common Stock5,077$25,077IBy Wife
Unit Warrants$2.5 4/18/05 C 81,391 4/18/05 4/18/08Common Stock81,391$281,391IBy Trust (1)
Unit Warrants$2.5 4/18/05 C 45,864 4/18/05 4/18/08Common Stock45,864$245,864IBy Trust (2)
Unit Warrants$2.5 4/18/05 C 126,884 4/18/05 4/18/08Common Stock126,886$2126,884D
Explanation of Responses:
(1)  By Profit Sharing Plan and Trust.
(2)  By Pension Plan and Trust.
(3)  Convertible and Bridge Notes were exchanged for Common Stock.
Leigh H. Severance 6/22/05
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
____________
Transaction Code:
    C    Conversion of derivative security.

Top
Filing Submission 0001108890-05-000506   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 3:02:02.4pm ET